| scholarly article | Q13442814 |
| P50 | author | Anderson J. Ryan | Q57617755 |
| P2093 | author name string | W Liu | |
| A Takeda | |||
| F Fan | |||
| L M Ellis | |||
| M Akagi | |||
| P F Mansfield | |||
| N Reinmuth | |||
| M F McCarty | |||
| O Stoeltzing | |||
| C Bucana | |||
| P2860 | cites work | In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note | Q28300836 |
| In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug | Q28754742 | ||
| In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note | Q29026600 | ||
| New strategies in anti-vascular cancer therapy | Q30762955 | ||
| Enhancement of radiation therapy by the novel vascular targeting agent ZD6126. | Q33183693 | ||
| Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude mice. | Q34136882 | ||
| The role of angiogenesis in tumor growth | Q34539790 | ||
| Targeting tumour vasculature: the development of combretastatin A4. | Q34572069 | ||
| Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy. | Q35032900 | ||
| Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. | Q35763510 | ||
| Endothelial cell diversity revealed by global expression profiling | Q35977148 | ||
| Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents | Q36291976 | ||
| Vascular attack as a therapeutic strategy for cancer | Q38037849 | ||
| VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice | Q40749355 | ||
| The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice | Q40762288 | ||
| Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci. | Q40898055 | ||
| The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. | Q41736480 | ||
| Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. | Q42522274 | ||
| Combretastatin A-4 prodrug inhibits growth of human non-small cell lung cancer in a murine xenotransplant model | Q43624619 | ||
| Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy | Q43956053 | ||
| Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate. | Q44293477 | ||
| The first international conference on vascular targeting: meeting overview. | Q44342351 | ||
| Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes | Q45868914 | ||
| Endothelial cells from diverse tissues exhibit differences in growth and morphology. | Q48511407 | ||
| ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. | Q52548713 | ||
| Microvascular structure of benign and malignant tumors of the colon in humans | Q72533581 | ||
| Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature | Q73352832 | ||
| Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors | Q73537065 | ||
| Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model | Q74086906 | ||
| Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases | Q74130353 | ||
| Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer | Q78358429 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 705-711 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer | |
| P478 | volume | 90 |
| Q34992944 | Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study |
| Q53561434 | In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes. |
| Q33863907 | Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts |
| Q34741259 | Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors |
| Q36611295 | Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel. |
| Q41552582 | Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models. |
Search more.